ENLIVEN THERAPEUTICS, INC. Public Float
ENLIVEN THERAPEUTICS, INC. (ELVN) had Public Float of $836.00 million as of 2025-06-30, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-03
- 2025-06-30: Entity Public Float $836.00M.
- 2024-06-28: Entity Public Float $683.80M.
- 2023-06-30: Entity Public Float $382.30M.
- 2022-06-30: Entity Public Float $20.82M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $836.00M 10-K · filed 2026-03-03 |
| 2024-06-28 | $683.80M 10-K · filed 2025-03-13 |
| 2023-06-30 | $382.30M 10-K · filed 2024-03-14 |
| 2022-06-30 | $20.82M 10-K · filed 2023-02-10 |
| 2021-06-30 | $87.93M 10-K · filed 2022-03-15 |
| 2020-06-30 | $190.48M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |